University Of Colorado Researchers Awarded $45 m Against Cyanamid

9 July 1997

- The US District Court for the District of Colorado has awardeddamages of $45 million against American Home Products Corp's subsidiary, American Cyanamid. The latter must pay the University of Colorado this sum for defrauding the university of a patent for Materna, a prenatal multivitamin supplement, reports Reuters. The university claims that two of its researchers invented the reformulated version of the supplement. However, while Cyanamid agrees that the researchers conducted studies relating to the reformulation, it denies that they were its inventors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight